drugset / Trial / NCT03556137

PET/MRI in the Diagnosis of Chronic Pain

NCT03556137 ↗

Phase 1 Unknown 190 enrolled Stanford University GE Healthcare · collab
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

Several studies have implicated involvement of sigma-1 receptors (SR1s) in the generation of chronic pain, while others are investigating anti SR1 drugs for treatment of chronic pain. Using \[18F\]-FTC-146 and positron emission tomography/magnetic resonance imaging (PET/MRI), the investigators hope to identify the source of pain generation in patients with chronic pain. The purpose of this study is to compare the uptake of \[18F\]FTC-146 in healthy volunteers to that of individuals suffering from chronic pain.

Timeline

Start
2018-07-16
Primary completion
2024-12-31
Completion
2024-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-FTC-146 Diagnostic / imaging agent 5 unknown —
Subject 18F-FTC-146 Diagnostic / imaging agent 10 unknown —